China vs Myanmar: New cases tested for RR-/MDR-TB
China
91.0%
in 2024
Myanmar
91.0%
in 2024
China rank
91st
Myanmar rank
91st
New cases tested for RR-/MDR-TB over time
- China
- Myanmar
How they compare
China currently reports 91.0% against 91.0% in Myanmar, a difference of 0.0%.
The two have swapped places 5 times across 12 shared years of data; in 2012 it was China ahead.
China ranks 91st and Myanmar ranks 91st of 192 countries.
Across the 2 decades both report, China averaged higher in 1 and Myanmar in 1.
Head to head by decade
| Decade | China | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 36.2% | 43.8% | 7.7% | Myanmar |
| 2020s | 87.2% | 84.0% | 3.2% | China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, China or Myanmar?
- China, at 91.0% against 91.0% in Myanmar as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between China and Myanmar?
- 0.0%, with China ahead.
- How many years of comparable data are there for China and Myanmar?
- 12 years are reported by both, from 2012 to 2024.
- How do China and Myanmar rank globally for new cases tested for rr-/mdr-tb?
- China ranks 91st and Myanmar ranks 91st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.